Poster Session
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
17 April 2023
-
P2166
Minimum inhibitory concentration evaluation of BWC0977, a novel bacterial topoisomerase inhibitor, against recent drug resistant clinical isolates
16 April 2019
-
P2863
Susceptibility trends and molecular characterization of beta-lactam-resistant pathogens isolated from intra-abdominal infections in Lebanon and Jordan: a 6-year evaluation of SMART data 2011-2016
Aline Hajj, Tarek Itani, Wail Hayagneh, Andre Adaime, Noha Hakime, May Mallah Hamdan, Jihane Maalouf, Reema Alsamarneh, Mary Motyl, Dan Sahm, Irina Alekseeva, Dolla Karam Sarkis
Session: Surveillance of resistance
Abstract Publication
15 April 2019
-
P1869
In vitro activities of ceftaroline and comparator agents against bacterial pathogens collected from patients with skin and soft tissue infections from Europe stratified by region: ATLAS Global Surveillance Program 2015-2017
15 April 2019
-
P1857
Characterization of isolates showing high MICs to cefiderocol from global surveillance study SIDERO-CR-2014/2016
15 April 2019
-
P1877
In vitro activity of tigecycline and comparator agents against Gram-negative and Gram-positive isolates from China in 2015-2017
15 April 2019
-
P1855
In vitro antibacterial activity of cefiderocol against an international collection of carbapenem-non-susceptible Gram-negative bacteria isolated from respiratory, blood, skin/soft tissue and urinary sources of infection: SIDERO-WT-2014-2016
Sean Nguyen, Meredith Hackel, Jennifer Hayes, Dan Sahm, Roger Echols, Masakatsu Tsuji, Yoshinori Yamano
Session: Cefiderocol in vitro
Abstract Publication
15 April 2019
-
P1851
Cefiderocol in vitro activity against Gram-negative clinical isolates collected in Europe: result from SIDERO-CR-2014/2016
Masakatsu Tsuji, Meredith Hackel, Yoshinori Yamano, Roger Echols, Christopher Longshaw, Davide Manissero, Dan Sahm
Session: Cefiderocol in vitro
Abstract Publication
15 April 2019
-
P1852
Cefiderocol in vitro activity against Gram-negative clinical isolates collected in Europe: result from three SIDERO-WT surveillance studies between 2014-2017
Masakatsu Tsuji, Meredith Hackel, Yoshinori Yamano, Roger Echols, Christopher Longshaw, Davide Manissero, Dan Sahm
Session: Cefiderocol in vitro
Abstract Publication
15 April 2019
-
P1854
In vitro and in vivo activity of cefiderocol against Burkholderia cepacia complex clinical isolates
Masakatsu Tsuji, Meredith Hackel, Roger Echols, Glenn Tillotson, David Fam, Yoshinori Yamano, Mark Wise, Krystyna Kazmierczak, Dan Sahm
Session: Cefiderocol in vitro
Abstract Publication
15 April 2019
-
P1853
Cefiderocol susceptibility and geographical analysis against globally isolated meropenem non-susceptible Gram-negative bacteria containing serine- and metallo-carbapenemase gene
Masakatsu Tsuji, Krystyna Kazmierczak, Meredith Hackel, Mark Wise, Roger Echols, Dan Sahm, Christopher Longshaw, Davide Manissero, Yoshinori Yamano
Session: Cefiderocol in vitro
Abstract Publication
14 April 2019
-
P1175
Antimicrobial activity of cefepime in combination with VNRX-5133 against a global 2018 surveillance collection of clinical isolates
14 April 2019
-
P1176
Antimicrobial activity of cefepime in combination with VNRX-5133 against a collection of beta-lactamase-producing Enterobacteriaceae
14 April 2019
-
P1145
In vitro activities of ceftazidime-avibactam and comparator agents against Enterobacteriaceae and Pseudomonas aeruginosa from Turkey collected through the ATLAS Global Surveillance Program 2012-2017
14 April 2019
-
P1144
In vitro activities of ceftazidime-avibactam and comparator agents against Enterobacteriaceae and Pseudomonas aeruginosa from Israel collected through the ATLAS Global Surveillance Program 2012-2017
14 April 2019
-
P1146
In vitro activity of ceftazidime-avibactam and comparator agents against Enterobacteriaceae and Pseudomonas aeruginosa collected from paediatric patients as part of the ATLAS Global Surveillance Program 2012-2017
14 April 2019
-
P1155
In vitro activities of aztreonam-avibactam and ceftazidime-avibactam against less commonly encountered Gram-negative bacteria collected during the ATLAS global surveillance program 2012-2017
14 April 2019
-
P1156
In vitro activities of aztreonam-avibactam and comparator agents against carbapenemase-producing Enterobacteriaceae collected during the ATLAS Global surveillance program 2015-2017
14 April 2019
-
P1151
Potentiation of oral cephalosporins and carbapenems by the addition of avibactam
14 April 2019
-
P1277
Distribution of carbapenemase-producing Enterobacteriaceae in Europe, ATLAS Global Surveillance Program 2016-2017
14 April 2019
-
P1147
In vitro activities of ceftazidime-avibactam and comparator agents against Pseudomonas aeruginosa from Europe stratified by region, ATLAS Global Surveillance Program 2017
+ load more
FAQ
I logged in, why is some content still locked?
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
How can I conduct a search of the content?
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
How can I filter content in the eLibrary?
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
What is the best way to search for "hot topics"?
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
How can I search for content containing two or more specific terms?
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
How can I find content that contains at least one term out of a chosen number of terms?
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
How can I search for content that contains a specific term but excludes another?
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
How do I search for all content that does not contain a specific term?
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
How can I remove a filter that I have applied before?
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
Can webcasts be downloaded?
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
May I contact the author of a document or a webcast’s presenter?
No, due to our privacy policy we cannot disclose any contact details of persons involved.